Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "tyrosine"

[News] Lenvatinib improves survival in refractory thyroid cancer

A phase 3 randomised trial has shown that lenvatinib, an oral, multitargeting tyrosine kinase inhibitor, significantly improves progression-free survival in radioiodine-refractory Lancet Neurology, 2 days ago

25 images for tyrosine

Labmate Online, 1 week ago
Capital Bay, 2 weeks ago
Capital Bay, 2 weeks ago
Tech Times, 2 weeks ago
Mayo Clinic College of Medicine, 3 weeks ago
Tech Beat, 4 weeks ago
My Startup World, 1 month ago
SPi World News, 1 month ago
OncLive, 1 month ago
Nylon Guys Magazine, 1 month ago

Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression

To read this article in full you may need to log in, make a payment or gain access through a site license (see right). Kidney International , (25February2015) | doi :10.1038/ki.2015.29 Stephen P McAdoo , Gurjeet Bhangal , Theresa Page , H ...
 Kidney International6 days ago

Pharmacyclics announces completion of toxicology studies for BTK inhibitor in RA

Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that longer-term toxicology studies for its newly developed Bruton's tyrosine kinase (BTK) inhibitor for rheumatoid arthritis, or RA, have been completed. The results of these preclinical ...
 News-Medical.Net4 days ago Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases  Individual.com4 days ago Pharmacyclics completes toxicology studies of BTK inhibitor in RA  News-Medical.Net4 days ago In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody  Fat Pitch Financials4 days ago
[x]  
ClinicSpace

Eisai Inc. (ESALF.PK) Release: LENVIMA (lenvatinib) Now Available Through Two Specialty Pharmacies, Accredo And Biologics, Inc. 2/27/2015

WOODCLIFF LAKE, N.J. , Feb. 27, 2015 /PRNewswire/ --Eisai Inc. announced today that LENVIMA (lenvatinib), a receptor tyrosine kinase inhibitor, is now available through two specialty pharmacies, Accredo and Biologics, Inc. LENVIMA is indicated for ...
 ClinicSpace4 days ago LENVIMA (lenvatinib) Now Available Through Two Specialty Pharmacies, Accredo and Biologics, Inc.  Securities Technology Monitor5 days ago LENVIMA(TM) (lenvatinib) Now Available Through Two Specialty Pharmacies, Accredo and Biologics, Inc.  Individual.com5 days ago 2/27/15 - LENVIMA?ยข (lenvatinib) Now Available Through Two Specialty Pharmacies, Accredo and Biologics, Inc.  Pharmacy Choice4 days ago
[x]  

Tyrosine Kinase Inhibition Engenders Mitochondrial Addictions

1 , 2 , 3 , Mark A. Gregory 3 , 4 , Catherine Pham-Danis 3 , 5 , Deborah DeRyckere 3 , 6 , Brett M. Stevens 3 , 7 , Vadym Zaberezhnyy 3 , 4 , Amanda A. Hill 3 , 6 , Lelisa Gemta 4 , Amit Kumar 8 , Vijay Kumar 8 , Michael F. Wempe 8 , ...
 Clinical Cancer Research1 day ago

Deregulated TyrosinePhenylalanine Metabolism in Pulmonary Tuberculosis Patients

Journal of Proteome Research
 Journal of Proteome Research1 day ago
EurekAlert!

CLL patients discontinue ibrutinib drug due to disease progression during clinical trials

About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during clinical trials, according to a study published online in ...
 News-Medical.Net4 days ago Prognosis With Ibrutinib Discontinuation in CLL Identified  Monthly Prescribing Reference4 days ago Researchers Examine Etiology of Ibrutinib Discontinuation in CLL  Physician's Briefing5 days ago Successful Nilotinib Treatment in a Child with Chronic Myeloid Leukemia  Case Reports in Oncology2 days ago
[x]  

Design, Synthesis and Biological Evaluation of Quinoxalin-2(1H)-one Derivatives as EGFR Tyrosine Kinase Inhibitors

Abstract: With the successful use of gefitinib and erlotinib in clinic, some potent EGFR tyrosine kinase receptor inhibitors have gained widespread concern in the treatment of ovarian or non-small-cell lung cancer. However, the emergence of ...
 Bionity.com4 days ago Linifanib - A Multi-Targeted Receptor Tyrosine Kinase Inhibitor and a Low Molecular Weight Gelator  RSC5 days ago Illuminating the Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance for the FGFR1 Gatekeeper Mutation: The Achilles Heel of Targeted Therapy  ACS Chemical Biology1 week ago
Med India

Resveratrol in Red Wine Mimics Tyrosine for Its Anti-aging Effect

The magical effect of the compound, resveratrol in red wine has proved to protect cells against damage from aging. These findings may be good news for red wine drinkers. Resveratrol is an organic compound found in dark grapes used to make red wine. Previous ...
 Med India2 months ago Why too much red wine is bad for you  Panorama.am6 days ago

Polymorphism analysis of tyrosine hydroxylase gene variable number of tandem repeats in various Korean dogs

March 2015 , Volume 37 , Issue 3 , pp 257-261 Date: 07 Nov 2014 , Bong-Hwan Choi , Dong-Hoon Lee , Yun-Jeong Kwon , Jungwoo Eo , Yuri Choi , Hoim Jeong , Jeong-An Gim , Tae-Hun Kim , Ji-Hong Ha , Kook-Il Han , ...
 Springer Link Journal6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - tyrosine
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less